Ellie Maghami, M.D.

"Best in the field and yet the most humble human being there is.” - Patient

Ellie Maghami, M.D., is Chief of the Division of Head and Neck Surgery and lead the multidisciplinary head and neck cancer team at the City of Hope, an NCI designated comprehensive cancer center. Her team offers patients the latest in evidenced based care, access to modern technologies, supportive care medicine, and cutting edge research with a fierce commitment to outstanding personalized care. She is a diplomat of the advanced training council in head and neck oncologic surgery and has broad clinical expertise with special interest in thyroid, aerodigestive, and salivary cancers. Proficient in minimally invasive surgery techniques utilizing laser and robotic technologies. Research interests involve robotic technologies, molecular profiling of tumors, complementary targeted and immune therapy approaches to management. She is an active member of the American Head and Neck Society and has served in its many committees. Dr. Maghami has the honor and distinction of the Norman and Sadie Lee endowed professorship in head and neck cancer.

• Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline. Ellie Maghami, Nofisat Ismaila, Adriana Alvarez, Rebecca Chernock, Umamaheswar Duvvuri, Jessica Geiger, Neil Gross, Bruce Haughey, Doru Paul, Cristina Rodriguez, David Sher, Hilda E Stambuk, John Waldron, Matt Witek, James Caudell. J Clin Oncol. 2020 Apr 23;JCO2000275. doi: 10.1200/JCO.20.00275. Online ahead of print. 
• Readmission and Complications after Robotic Surgery – Experience of 10,000 Operations at a Comprehensive Cancer Center. Pooya Banapour MD1, Bertram Yuh MD1, Avinash Chenam MD1, Jim K. Shen MD1, Nora Ruel MA2, Ernest S. Han MD1, Jae Y Kim MD1, Ellie G Maghami MD1, Alessio Pigazzi MD1, Dan J Raz MD1, Gagandeep P Singh MD1, Mark Wakabayashi MD1, Yanghee Woo MD1, Yuman Fong MD1, Clayton S Lau MD1. Journal of Robotic Surgery. In review.
• Impact of histologic grade in papillary thyroid carcinoma:  mortality risk and response to external beam radiation therapy. Allen S. Ho MD, Michael Luu MPH, Laurel Barrios BA, Shikha Bose MD, Xuemo Fan MD, PhD, Evan Walgama MD, Jon Mallen St.-Clair MD, PhD, Usman Alam, Iram Shafqat, De-Chen Lin PhD, Yufei Chen MBBS, Jenny Van Eyk PhD, Ellie G. Maghami, Glenn D. Braunstein MD, Wendy L. Sacks MD, Zachary S. Zumsteg MD. Cancer. CNCR-20-0100. Submitted. In review.
• Myeloid Cell-Selective STAT3 Inhibition Sensitizes Head and Neck Cancers to Radiation Therapy and Stimulates T cell-Mediated Tumor Regression. Dayson Moreira1,5, Sagus Sampath2, 5, Haejung Won1, Seok Voon White1, Chongkai Wang1, Peter Lee1, William C. Spanos3, Ellie Maghami4, Erminia Massarelli5, and Marcin Kortylewski1,6
• Bonjoc KJ, Young H, Warner S, Gernon T, Maghami E, Chaudhry A. Thyroid cancer diagnosis in the era of precision imaging. Journal of Thoracic Disease. 2019. Accepted for publication Aug 1 2019 
• Factors Predicting for Patient Refusal of Head and Neck Cancer Therapy. Arya Amini MD1#, Vivek Verma MD2#, Richard Li MD1, Nayana Vora MD1, Robert Kang MD MPH3, Thomas J. Gernon MD3, Sue Chang MD4, Sana Karam MD PhD5, Erminia Massarelli MD MS6, Ellie G. Maghami MD3, Scott Glaser MD1. Head Neck Sep 2019
• Postoperative radiation performed at the same surgical facility associated with improved overall survival in oral cavity squamous cell carcinoma. Amini A, Stokes WA, Jones BL, Sampath S, Kang RS, Gernon TJ, Maghami EG, Massarelli E, Bradley CJ, Karam SD. Head Neck. 2019 Feb 9
• Clinical Trials in Management of Anaplastic Thyroid Carcinoma; Progressions and Set Backs: A Systematic Review. Salehian B, Liem SY, Mojazi Amiri H, Maghami E. Int J Endocrinol Metab. 2019 Jan 13;17(1)
• Outcomes of surgical management of dysplastic oral mucosal lesions versus observation: A systematic analysis. Pelin Güneri, Ellie Maghami, Hayal Boyacıoğlu, Allen S Ho, Joel B Epstein Otorhinolaryngol Head Neck Surg, Jan 2019, DOI: 10.15761/OHNS.1000201
• Multidisciplinary Management of Head and Neck Cancer. Allen Ho and Ellie Maghami, Co-editors. January 2018. Springer
• Decreasing Utilization of Concurrent Chemotherapy in Human Papillomavirus-Positive Oropharyngeal Cancer: Analysis of National Patterns of Care. R. Li, D. Akhavan, S. Sampath, N.L. Vora1, E. Maghami, T. Gernon, R. Kang, E. Massarelli, A. Amini. International Journal of Radiation Oncology, Biology, and Physics. November 1, 2018Volume 102, Issue 3, Supplement, Page e329, https://doi.org/10.1016/j.ijrobp.2018.07.1014
• Factors Predicting for Patient Refusal of Definitive Treatment in Non-Metastatic Head and Neck Cancer A. Amini1, R. Li1, A. Shinde1, R. Nelson2, S. Sampath1, N.L. Vora1, R. Kang3, T. Gernon3, E. Maghami3, A. Hurria4, E. Massarelli4, S.M. Glaser1. November 1, 2018Volume 102, Issue 3, Supplement, Pages e404–e405. https://doi.org/10.1016/j.ijrobp.2018.07.1192
• Transoral Robotic Surgery. Robert Kang, Thomas Gernon, Ellie Maghami. The SAGES Atlas of Robotic Surgery pp 445-452, Sep 2018, https://doi.org/10.1007/978-3-319-91045-1_38
• Personalizing Postoperative Treatment of Head and Neck Cancers. Ellie Maghami, MD, FACS, Shlomo A. Koyfman, MD, and Jared Weiss, MD. ASCO Educational Book. Issue 38. May 2018.
• Surgical Perspectives in Head and Neck Cancer. Ho AS, Maghami E. Cancer Treat Res. 2018;174:103-122.
• Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients. Sampath S, Won H, Massarelli E, Li M, Frankel P, Vora N, Vora L, Maghami E, Kortylewski M. Oncotarget. 2018 Feb 2;9(13):11279-11290. doi: 10.18632/oncotarget.24397. eCollection 2018 Feb 16.